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disease and an acute decompensation whose prognosis remains severe for
mother and fetus. The cure reference coarctation of the aorta is surgical treat-
ment to take place before the pregnancy. The angioplasty finds its place in the
restenosis. Above all through, preventing the coarctations of the aorta compli-
cated must be systematically and repeatedly search in the young age, raising
the problematic of congenital cardiopathies detection in Morocco.
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Balloon atrial septostomy (BAS) increases peripheral oxygen saturation in
neonates with transposition of the great vessels (TGV). Effect of BAS on cere-
bral oxygenation remains little known. We aimed to describe the modification
of regional cerebral tissue oxygen saturation (rcSaO²) during the catheteriza-
tion.
Methods: we prospectively included 6 neonates with TGV and restrictive
inter-atrial shunt who required BAS. BAS was performed in catheterization
laboratory by an interventional pediatric cardiologist. rcSaO² was measured
using near-infrared spectroscopy (NIRS) during the whole procedure.
Results: Median rcSa0² at the beginning of the procedure was 52.5%
ranging from 21% to 78%. Median rcSaSaO² after the BAS was 69.5%
ranging from 64% to 94%. The rcSa0² increased significantly immediately
after the BAS (p=0.0273 by Wilcoxon signed rank test). Median rcSa0² delta
between before and after BAS was 19% ranging from 11 to 43%. The rcSaO²
delta was higher although not significantly when rcSa02 before the BAS was
less than 50% (31% vs 16%, p=0.14). Linear regression analysis revealed that
the delta of rcSaO² was significantly inversely related to the rcSa0² at the
beginning of the procedure (Delta= –0.45 x rcSaO²av + 45.8, p=0.37,
R²=0.70). 
Conclusion: BAS improves cerebral oxygen saturation during the catheter-
ization in neonates with TGV and restrictive inter-atrial shunt. The increase is
proportional to the degree of alteration before the procedure.
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Dissecting progenitor cell contributions to the developing heart
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Cardiac progenitor cells of the second heart field (SHF) contribute to the
poles of the elongating embryonic heart. Perturbation of SHF development
leads to a spectrum of congenital heart defects. Recent evidence suggests that
distinct regions of the heart are pre-patterned in the SHF. For example the
dell22q11.2 or DiGeorge syndrome gene Tbx1 is required in the SHF for
development of the inferior wall of the embryonic outflow tract, giving rise to
subpulmonary myocardium. Characterization of the expression of an enhancer
trap transgene at the Hes1 locus, encoding a transcriptional repressor, has
identified a complementary Notch-dependent Hes1+ TBX1 – subpopulation of
SHF cells giving rise to future subaortic myocardium. Using transcriptomic
analysis we have characterized the genetic signatures of future subaortic and
subpulmonary myocardium and identified Pparg among the genes enriched in
future subpulmonary myocardium. Genetic and explant analyses have shown
that Hes1 controls the molecular signature of future subaortic myocardium
through direct transcriptional repression of Pparg. Our results reveal that dis-
tinct genetic regulatory networks control different progenitor cell contributions
to the developing heart. We also investigated the potential role of Hes1 in the
maintenance of residual SHF progenitors in the fetal heart. Our initial results
have identified Hes1+ cells in the fetal heart and suggest that Hes1 deletion
impacts negatively on residual progenitor cell numbers. Together, our study
identifies a role for Hes1 in the regulation of cardiac progenitor cell fate and
maintenance in the definitive heart of clinical importance for heart repair.
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Introduction: The congenital supravalvular mitral ring is a rare subtype of
congenital mitral stenosis. This form is poorly understood and thus underesti-
mated. It has a good prognosis with appropriate management. The identifica-
tion of this entity remains unrevealed in the literature, only less than 100 cases
were reported. The aim of this study was to share the diagnostic and thera-
peutic experiences of the Casablanca pediatric cardiology unit.
Methods: Between December 2008 and January 2014, 1927 patients with
congenital heart disease were collected retrospectively in the Ibn Rochd car-
diology department of Casablanca university hospital.
Results: 19 patients had congenital mitral stenosis (0.01% of the entire
series), 8 of them were related to a supravalvular mitral ring. The sex ratio
M / F was 1: 1. The median age was 10 months [5-168]. For all patients,
the diagnosis was made by echocardiography. The average mean mitral
valve gradient was 14± .8mmHg. Associated anomalies were: interventric-
ular communication (n=3), coarctation of the aorta alone (n=1), coarcta-
tion of the aorta associated with a bicuspid aortic valve (n=2), Double
Outlet Right Ventricle (DORV) (n=1) and a complex congenital cardio-
pathy (n=1). The surgery was indicated to 7 patients; the 8th patient had
DORV with Eisenmenger. The supra-mitral ring was surgically resected to
4 patients with a good surgical outcome, 2 patients are awaiting for sur-
gery and one patient was lost to view. No deaths per or postoperative were
noted.
Conclusion: The supravalvular mitral ring is a rare variety of congenital
mitral stenosis. It is often underestimated and potentially serious. The echocar-
diography is the diagnosis key. Surgical treatment is usually indicated. After
resection, the prognosis is good without risk of recurrence and that improves
long-term survival.
